Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Labs says it will pay $170M upfront for experimental chronic pain drug from PanGenetics
Yahoo/AP
Thursday, November 12, 2009 - 10:49am
tags:
PanGenetics, Abbott Laboratories, chronic pain
Isis spin-off gets a fresh injection of venture funds
Fierce Biotech
Thursday, November 12, 2009 - 10:04am
tags:
venture capital, Isis Pharmaceuticals, Altair
CTIC Reports, Awaiting FDA Decision
Yahoo/Zacks.com
Thursday, November 12, 2009 - 10:03am
tags:
FDA, Cell Therapeutics, pixantrone
Bayer to up R&D spend as Higgins looks to the future
PharmaTimes
Thursday, November 12, 2009 - 9:30am
tags:
Bayer, R&D
Novartis Gives Thumbs Down To R&D In India
Pharmalot
Thursday, November 12, 2009 - 9:19am
tags:
R&D, India, Novartis
What Pfizer, KKR and Goldman (Reportedly) Want: Generics!
WSJ Online
Thursday, November 12, 2009 - 9:18am
tags:
generics, Pfizer, Ratiopharm
Spectrum Posts Encouraging Zevalin Sales
TheStreet.com
Thursday, November 12, 2009 - 9:17am
tags:
Zevalin, Spectrum Pharmaceuticals
Cytokinetics' Market Potential
Seeking Alpha
Thursday, November 12, 2009 - 8:46am
tags:
Cytokinetics
Dendreon loses $45.6M in Q3
Bizjournals.com
Thursday, November 12, 2009 - 8:43am
tags:
Dendreon, earnings
Band-Aid Won't Stop Generic Bleeding at Johnson & Johnson
BNET Pharma
Thursday, November 12, 2009 - 8:26am
tags:
generics, JNJ, Risperdal, Topamax
Big Pharma Scramble for a Piece of the Vaccine Pie
Minyanville
Thursday, November 12, 2009 - 8:24am
tags:
vaccines, Pfizer, Abbott Laboratories, JNJ, GSK, Merck, Novartis
MannKind: Trader Says This Drug Firm Will Snap Up 50% By Mid-2010
CNBC
Thursday, November 12, 2009 - 8:23am
tags:
MannKind
Data From Studies of Pfizer Neurontin Drug May Have Been Skewed
Bloomberg
Thursday, November 12, 2009 - 8:22am
tags:
Pfizer, Neurontin
Who Wants to Talk to the FDA About Google and Facebook?
WSJ Online
Wednesday, November 11, 2009 - 7:05pm
tags:
FDA, drug ads, social media
When Rival Drug Makers Compare Notes On Safety Problems
WSJ Online
Wednesday, November 11, 2009 - 5:57pm
tags:
Elan, Biogen Idec, Roche, Tysabri, drug safety
Marcial: Is Eli Lilly Ripe for a Rebound?
Businessweek
Wednesday, November 11, 2009 - 5:56pm
tags:
Eli Lilly
FTC Expresses Concern About Drug Makers' Practices
WSJ Online
Wednesday, November 11, 2009 - 5:55pm
tags:
FTC, generics, Celgene, GSK
Regeneron/Sanofi: Now That's What I Call a Drug Deal
Motley Fool
Wednesday, November 11, 2009 - 5:53pm
tags:
Regeneron, partnerships, Sanofi
Merck CEO mulls successor after merger
Reuters
Wednesday, November 11, 2009 - 11:23am
tags:
Richard Clark, Merck, Schering Plough, M&A, Pharma CEOs
IMS: Reform to lift drug sales 3.5% annually
Fierce Pharma
Wednesday, November 11, 2009 - 11:22am
tags:
prescription data, drug sales, IMS

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.